The germ cell tumor lines 2102Ep and NT2 (Podrygajlo et al., 2009) were treated with 1.4 μM cisplatin and the PARP inhibitors LS-75 (10 μM), pirenzepine (10 μM), 3-AB (100 μM), DPQ (1 μM), and PJ34 (1 μM). This evidence concerns the gene PARP1 and germ cell tumor.